ReviewFrontiers in cardiovascular medicine2024

Risk of cardiovascular toxicity with combination of immune-checkpoint inhibitors and angiogenesis inhibitors: a meta-analysis.

Alessandro Inno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.